- Statement 1 is incorrect: Covishield, manufactured by the Serum Institute of India, is the Oxford- AstraZeneca vaccine. It uses a viral vector platform (specifically, a modified chimpanzee adenovirus) to deliver the genetic material for the SARS-CoV-2 spike protein. It is not an mRNA vaccine. - Statement 2 is correct: Sputnik V, developed by the Gamaleya Research Institute in Russia, is an adenoviral vector vaccine. It uses two different human adenoviruses (Ad26 and Ad5) for the two doses. - Statement 3 is correct: COVAXIN, developed by Bharat Biotech in India, is an inactivated pathogen- based vaccine. It uses the whole SARS-CoV-2 virus, which has been chemically inactivated so it cannot replicate or cause disease, but can still trigger an immune response.
In the context of vaccines manufactured to prevent COVID-19 pandemic, consider the following statements: The Serum Institute of India produced COVID-19 vaccine named Covishield using mRNA platform. Sputnik V vaccine is manufactured using vector based platform. COVAXIN is an inactivated pathogen based vaccine. Which of the statements given above are correct ?
Asked in UPSC IAS 2022 · Topic: Diseases and Treatment (Vaccination: Principles, Types of Vaccines, and Immunization Programs)
More Biology questions
- The vaccine for Polio was first prepared by:
- D.T. P. vaccine is given to protect from
- The vaccine for Hepatitis – B Birth dose administered through which route? (1) Intramuscular (2) Intradermal (3) Subcutaneous (4) Oral (5) Question not attempted
- First vaccine was developed by
- What is the name of the institute that developed first Indian indigenously pneumonia vaccine?
- Injection of weakened microbes to confer resistance to a disease is known as-
- Which viral disease is caused by *Varicella- zoster* virus?
- 'Bird Flue' is caused by influenza virus type